Dean Radin, Ph.D.
Dean Radin, PhD, is a pioneering consciousness researcher and Associated Distinguished Professor at the California Institute of Integral Studies. He earned an MS in electrical engineering and a PhD in psychology from the University of Illinois, Urbana-Champaign. Earlier in his career, he held appointments at AT&T Bell Labs, Princeton University, University of Edinburgh, and SRI International. He is author or co-author of hundreds of technical and popular articles, four dozen book chapters, and four popular books: The Conscious Universe (1997), Entangled Minds (2006), Supernormal (2013), and Real Magic (2018). Dean is also co-inventor of genetic neuropsychology, a new branch of science for improving behavior and cognition by genetically optimizing brain functioning.
John L. Mee
John Mee is a senior research and development executive with extensive experience transforming new technologies into commercially-successful products. One of the architects of the Information Age, Mr. Mee worked at the highest echelons in the computer industry, directing R&D programs involving thousands of engineers which produced new large computer systems hardware designs. He is a leading thinker in the emerging field of human genetic cognitive enhancement and holds multiple patents pending on genetic engineering methods for enhancing human cognition. The technology these inventions introduce is grounded in Mr. Mee's deep and pragmatic understanding of engineering and his ability to develop high-volume applications which drive manufacturing economies of scale.
Barry J. Linder, MD
Chief Medical Officer
Barry J. Linder, MD, is a seasoned medical technology executive, physician business leader, and entrepreneur with over 30 years of extensive healthcare experience. Skilled in developing innovative, next generation medical devices and information systems to address unmet needs in healthcare. Barry has been awarded ten US patents. He has extensive management and operational experience in executive leadership positions in privately financed growth and commercial stage medical device companies, as well as senior positions across multiple divisions within a large, integrated, healthcare delivery network.
David Hitt II, MS, JD
Mr. Hitt received BS degrees in both Physics and Business and Public Administration from the University of Texas at Dallas in 1982. He then received an MS degree in Taxation at Baylor University in 1983 and his JD from Southern Methodist University in 1987. He practiced transactional intellectual property law for 30 years (at his own firm, Hitt Gaines, for 22 of those years), gaining extensive experience in patent procurement and counseling in a wide array of physical, electrical, mechanical, mathematical, and computer technologies. Mr. Hitt left the practice of law in 2016 to focus full-time on barrier strategy, teaming with other entrepreneurs to launch and lead early-stage companies, bringing to market significant technologies, taking an equity position, and acting as a statutory board member, advisory board member, or c-suite officer.
James H. Fallon, Ph.D.
James H. Fallon, Ph.D. is Professor of Psychiatry and Human Behavior at the University of California, Irvine. He holds a Sloan Fellowship, Senior Fulbright Fellowship and NIH Research Career Award. He was Chair of the UCI Faculty and Academic Senate and Chair of the UCI College of Medicine. He sits on numerous corporate boards and national think tanks for science, biotechnology, the arts, and the military. He is a Subject Matter Expert to the Pentagon in the field of cognition and war, Vice Chair of the American Land forces Institute, and a founding member of the Vatican Arts and Technology Council.
His research program is focused on adult stem cells, chemical neuroanatomy and circuitry, higher brain functions, and brain imaging, including imaging genetics studies of depression, schizophrenia, addiction, language disorders, personality, intelligence, consciousness and anesthesia, human cortical development, sleep, emotional memory, and modeling of neural circuits.
Troy Rohn, Ph.D.
Dr. Troy T. Rohn received his Ph.D. in pharmacology from the University of Washington in 1994 and completed postdoctoral research at INSERM (Paris, France), Montana State University, and the Institute for Memory Impairments and Neurological Disorders at UC Irvine. Currently, Dr. Rohn is a professor in the Department of Biological Sciences at Boise State University where he has taught and performed research for the past 20 years, publishing over 60 peer-reviewed articles. His research focuses on the role that certain proteases play in promoting the pathology associated with different neurodegenerative diseases. More recently, his research has focused on how the APOE4 gene contributes to late-onset AD risk.
Tracy Brandmeyer, Ph.D.
Joe Lopardo is founder and CEO of Lumen Society, a private, global community of conscious funders (family offices, institutional investors, HNW, VCs, philanthropists, and angels) and select world-class founders and change makers, who are dedicated to evolving themselves and funding/building organizations advancing human conscious-ness. Joe is passionate about human potential, evolving into our best/highest selves and human consciousness, which stemmed from his personal growth journey. After building several companies, he came to realize his gifts were building authentic connections, being a bridge for meaningful introductions and connecting the dots around impactful opportunities. Joe is working at the intersection of his passions and gifts, creating a positive impact in the world through the Lumen Society.
Dr. Tracy Brandmeyer is a Postdoctoral Research Fellow at the University of California’s Center for Integrative Medicine, where she is working to advance our understanding of the effects of meditation and mindfulness practices by identifying their underlying neural mechanisms and circuitry. Her research covers topics including cognitive control, emotion regulation, executive function, and attention. Tracy earned her Ph.D. in Cognitive Neuroscience from Paul Sabatier Université, Toulouse, France, and her M.Sc. in Neuropsychology from Radboud Universiteit, Nijmegen, the Netherlands.
With 25 years as a specialist in working with breakthrough innovations, John Fellows has an extensive background in the business of ideas and intellectual properties. He has worked with internet, search engine, water, and bio-engineering start-ups at the pioneering stages and as these sectors emerged. He also has diversified business experience in private and public companies including AT&T, IBM and major brokerage firms in North America. John has a wide range of understanding and the ability to communicate with subject matter experts in science, technology, marketing, and mathematics.
William (Bill) Melton is the Founder and Chairman of the Board of Directors of Global Internet Ventures. For more than 20 years, Mr. Melton has been an entrepreneur bringing technology to the financial industry. He was the original founder of VeriFone Inc, the transaction automation company that has made credit authorization terminals ubiquitous on retail counters throughout the world. Bill was also an early investor in America Online and served on its Board of Directors for a decade. He currently serves on the Board of several private early stage technology companies. He holds a master’s degree in Asian Studies and Chinese Philosophy.
Executive Producer/Media Advisor
Scott Paskoff is a recognized entertainment leader, with a keen eye for finding untapped IP and developing it for television and film. With a reputation for originality, strong management skills, business acumen and team building, and a proven track record during 25 years in the domestic and international entertainment industry, Scott has developed and produced ground-breaking unscripted programming for the major networks and cable.
Globally, Scott worked as an Acquisitions / Distribution, Series & Formats Consultant for DRG TV (UK) responsible for sourcing acquisitions, formats, series, and co-productions in the U.S. and Canada for global distribution. Prior to DRG, Scott worked as a development executive for Keshet/Dick Clark Productions, Bodega Pictures and Fly On The Wall Entertainment.
Tom Lytle is a top pharmaceutical and biotechnology executive with 40 years of industry experience. He has held senior management positions in pharmaceutical and biotechnology sales, marketing, and new product commercialization with leading companies including Amgen, as Vice President–New Products, and Pfizer, as Vice President–Marketing.
Tom also served as Adjunct Professor at the University of the Sciences in Philadelphia for 6 years teaching graduate level courses in Sales, Pharmaceutical Marketing, and Competitive Intelligence & Business Strategy. In 1993, he retired from the US Army as a Colonel after 26 years of active and reserve service. Tom received a BBA in Marketing from Western Michigan University, and a MBA in Marketing and Management from LaSalle University in Philadelphia.
Lucyna Urbanczyk has a Master’s Degree in Chemical Engineering, with over 25 years of Biotech/Pharmaceutical industry experience in Quality Control, Biochemistry, Immunology, Molecular Biology and Immunochemistry Research.
Lucyna is also an experienced Regulatory Affairs Specialist in designing and implementing regulatory strategies, and supporting the application through licensure and post approval process with the FDA, Health Canada, European and other international regulatory agencies.
Randal Koene, Ph.D.
Randal Koene earned his Ph.D. in Computational Neuroscience at the Department of Psychology at McGill University, and his M.Sc. in Electrical Engineering at Delft University of Technology. He has served as Director of the Department of Neuroengineering at the Fatronik-Tecnalia Institute in Spain, the third largest private research organization in Europe, as well as Professor at the Center for Memory and Brain of Boston University, and lead scientist at Kernel. He is also co-founder of the Neural Engineering Corporation of Massachusetts.
Stanley Underwood North III
Stanley North has practiced corporate, commercial, and international law for 30 years; including M&A, securities, contracts and intellectual property advice. He is experienced in international and domestic commercial transactions in life sciences, alternative energy, housing technologies, intellectual property and licensing. He has a global client base spanning blue chip through start-up companies. JD, NYU Law School. Former Chair, NJ Bar Committee on International Trade & Investments.